Results: 237

Vaccination status of people living with HIV/AIDS in outpatient care in Fortaleza, Ceará, Brazil

Braz. j. infect. dis; 20 (5), 2016
Abstract Antiretroviral therapy has increased the survival of patients with HIV/AIDS, thus necessitating health promotion practice with immunization. Vaccines are critical components for protecting people living with HIV/AIDS (PLWHA). The purpose of study was to analyze the vaccination status of PLWHA in...

Adherence to antiretroviral therapy of Brazilian HIV-infected children and their caregivers

Braz. j. infect. dis; 20 (5), 2016
Abstract Background Successful treatment of HIV-positive children requires a high level of adherence (at least 95%) to highly active antiretroviral therapy. Adherence is influenced by factors related to the child and caregivers. Objectives To evaluate children and caregivers characteristics associated ...

Abacavir-induced liver toxicity

Braz. j. infect. dis; 20 (5), 2016
Abstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcoh...

Respuesta virológica e inmunológica a la terapia anti-retroviral en pacientes portadores de infección por VIH atendidos en una red de salud académica de Chile

Rev. chil. infectol; 33 (5), 2016
Introduction: Red Salud UC is an Academic health network where HIV-infected patients from the public and private health system are followed by a multidisplinary team. Aim: To determine virologic and immunologic response after 144 weeks of starting first antiretroviral therapy in these patients. Methods: ...

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy

Braz. j. infect. dis; 20 (4), 2016

Porphyria cutanea tarda in a HIV- positive patient

An. bras. dermatol; 91 (4), 2016
Abstract: This is a case report about Porphyria cutanea tarda (PCT) and its relationship with the infection caused by the human immunodeficiency virus (HIV). Cutaneous porphyria is an illness caused by enzymatic modification that results in partial deficiency of uroporphyrinogen decarboxylase (Urod), whi...

Síndrome de Cushing iatrogénico por corticoides inhalados en paciente VIH

Rev. méd. Chile; 144 (7), 2016
We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five...

Ergotismo por uso simultáneo de ergotamínico y terapia antirretroviral: Report of one case

Rev. méd. Chile; 144 (6), 2016
High activity antiretroviral therapy may exacerbate the activity of ergot alkaloids due to an inhibition of cytochrome P450. We report a 57 years old female with AIDS treated with lamivudine, zidovudine, atazanavir, ritonavir and cotrimoxazole presenting with ischemic signs in the four limbs. There was a...

Cambio de la terapia antiretroviral de gran actividad asociada a reacciones adversas medicamentosas en un centro especializado en Venezuela

Invest. clín; 57 (1), 2016
Las reacciones adversas medicamentosas (RAMs) representan la principal causa de cambio de la terapia antiretroviral de gran actividad (TARGA) de primera línea y, por tanto, el principal limitante en el seguimiento a largo plazo de los pacientes con el virus de la inmunodeficiencia humana (VIH) en tratam...

Informe final: encuesta de resistencia del VIH a los medicamentos antirretrovirales, Guatemala 2015-2016

Informe que presenta los resultados de las encuestas realizadas según las recomendaciones de la OMS, para la vigilancia de resistencia pretratamiento y resistencia adquirida del VIH....